An interventional study of peer-driven intervention in Obstructive Sleep Apnea Syndrome, sponsored by AGIR à Dom. Not yet recruiting. Open to participants aged 18 Years to 120 Years. Per ClinicalTrials.gov, last updated 2025-02-20.
Sponsored by AGIR à Dom · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The primary objective of this randomized clinical trial is to evaluate the role of patient researchers in promoting the resumption of CPAP therapy in apneic patients who had previously stopped CPAP
Obstructive Sleep Apnoea syndrome (OSA) is one of the most frequent chronic disease presenting with or without symptoms of excessive daytime sleepiness (EDS) and being accompanied by neurocognitive, cardiovascular and metabolic complications.
The first line therapy of obstructive sleep apnoea is continuous positive airway pressure (CPAP). CPAP is highly effective in symptomatic patients for reducing EDS and improving daily functioning, cognitive function, mood and quality of life. However, success of CPAP treatment is hampered by long term nonadherence in nearly half of patients. Non adherence to CPAP is less and less related to technical problems, but rather to users' profile, their representations of OSA and the benefits experienced from CPAP. Cognitive-behavioural and motivation enhancement therapies can promote adherence to CPAP treatment. In addition to health professionals, patients and public involvement (PPI) is more and more advocated in the field of education and research. Nevertheless, the level of evidence regarding efficacy of PPI and patient researchers remains to be demonstrated. The aim of this randomized clinical trial is to evaluate the role of patient researchers in promoting the resumption of CPAP therapy in apneic patients who had previously stopped CPAP
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
This study's planned enrollment of 208 is above the median of 52 across 1,476 interventional studies indexed under Sleep Apnea, Obstructive.
Browse Sleep Apnea, Obstructive studies →AGIR à Dom is the lead sponsor of 17 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervention conducted by trained patient researchers to restart CPAP in addition to usual care
Behavioral: peer-driven intervention
Usual care
Trained patient researchers will conduct 3 motivational sessions, according to the principle of motivational enhancement and cognitive-behavioral therapies, by videoconference meetings of 45 to 60 minutes duration with 5 to 8 patients within 6 months after each patient's inclusion.
Evaluate the impact of a 6-month, peer-driven intervention to promote the resumption of CPAP after discontinuation
The range of patients reusing CPAP in the intervention group The difference in percentages of patients who reuse CPAP between the peer-driven intervention group and the control group.
Time frame: 6 months after inclusion
Evaluate the impact of the peer-driven intervention on adherence to CPAP compared to the control group
the difference in CPAP compliance (average hours of use/night) between the AP intervention group and a control group
Time frame: 6 month after inclusion
Evaluate the impact of the peer-driven intervention on adherence to CPAP compared to the control group
the difference in percentages of patients who reuse to CPAP with at least 4 hours' use /night for 70% of nights
Time frame: 6 month after inclusion
Disease-specific quality of life
The Functional Outcomes of Sleep Questionnaire (FOSQ10) will be completed at inclusion (M0) and at the 6-month follow-up (M6). This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: At inclusion and after 6 months
Patient Self-Efficacy Measure for Sleep Apnea
The Self-Efficacy Measure for Sleep Apnea (SEMSA) questionnaire, a tool with strong psychometric properties and with the potential for identifying patient perceptions will be completed at inclusion (M0) and at the 6-month follow-up (M6). This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: At inclusion and after 6 months
Patient knowledge, skill, and confidence for self-management
The Patient Activation Measure (PAM) qestionnaire, a measure that assesses patient knowledge, skill, and confidence for self-management, will be completed at inclusion (M0) and at the 6-month follow-up (M6) This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: At inclusion and after 6 months
Patient satisfaction and peer satisfaction
Patient satisfaction with the peer-driven intervention at 6 months will be measured on a 4-point Likert scale : very dissatisfied, dissatisfied, satisfied, very satisfied. Satisfaction of PI representatives will be measured on a 4-point Likert scale: very dissatisfied, dissatisfied, satisfied, very satisfied.
Time frame: At 6 month after inclusion
Feasibility and the execution of the peer-driven intervention
Evaluate the feasibility and the execution of the peer-driven intervention
Time frame: At 6 month after inclusion
Age
This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
Gender
This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
BMI Body Mass Index
This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
marital status with infants (<10 years) or not
This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
Education level
This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
employment and socio-professional status
This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
alcohol-smoking status
This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
fragility and social precariousness
EPICES score will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
medication adherence
Girerd Score. This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
OSA history
date of diagnosis of OSA
Time frame: inclusion
CPAP treatment
Date of initiation of CPAP and date and cause of CPAP discontinuation
Time frame: inclusion
Baseline Apnea-Hypopnea Index (AHI)
This variable will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
Excessive daytime sleepiness (EDS score)
Epworth Sleepiness Scale will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
Comorbidities
Charlson index will be used to assess predictors of positive response to patient researcher intervention
Time frame: inclusion
No study locations are listed for this record.
Plan to share: No
Start is estimated for Feb 2025.
Of 511 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 0 months is below that.
Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
AGIR à Dom